Cargando…

Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease

OBJECTIVE: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement and adherence to a low-energy diet (LED) as a treatment option for NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Scragg, Jadine, Hallsworth, Kate, Taylor, Guy, Cassidy, Sophie, Haigh, Laura, Boyle, Marie, Anstee, Quentin, McPherson, Stuart, Avery, Leah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323391/
https://www.ncbi.nlm.nih.gov/pubmed/34326098
http://dx.doi.org/10.1136/bmjgast-2021-000678
_version_ 1783731232008306688
author Scragg, Jadine
Hallsworth, Kate
Taylor, Guy
Cassidy, Sophie
Haigh, Laura
Boyle, Marie
Anstee, Quentin
McPherson, Stuart
Avery, Leah
author_facet Scragg, Jadine
Hallsworth, Kate
Taylor, Guy
Cassidy, Sophie
Haigh, Laura
Boyle, Marie
Anstee, Quentin
McPherson, Stuart
Avery, Leah
author_sort Scragg, Jadine
collection PubMed
description OBJECTIVE: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement and adherence to a low-energy diet (LED) as a treatment option for NAFLD. DESIGN: 23 patients with NAFLD enrolled in a LED (~800 kcal/day) were individually interviewed. Transcripts were thematically analysed. RESULTS: 14/23 patients achieved ≥10% weight loss, 18/23 achieved ≥7% weight loss and 19/23 achieved ≥5% weight loss. Six themes were generated from the data. A desire to achieve rapid weight loss to improve liver health and prevent disease progression was the most salient facilitator to engagement. Early and significant weight loss, accountability to clinicians and regular appointments with personalised feedback were facilitators to engagement and adherence. The desire to receive positive reinforcement from a consultant was a frequently reported facilitator to adherence. Practical and emotional support from friends and family members was critically important outside of the clinical setting. Irregular working patterns preventing attendance at appointments was a barrier to adherence and completion of the intervention. CONCLUSIONS: Engagement and adherence to a LED in patients with NAFLD were encouraged by early and rapid weight loss, personalised feedback and positive reinforcement in the clinical setting combined with ongoing support from friends and family members. Findings support those identified in patients who completed a LED to achieve type 2 diabetes remission and highlight the importance of behaviour change support during the early stages of a LED to promote adherence.
format Online
Article
Text
id pubmed-8323391
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-83233912021-08-19 Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease Scragg, Jadine Hallsworth, Kate Taylor, Guy Cassidy, Sophie Haigh, Laura Boyle, Marie Anstee, Quentin McPherson, Stuart Avery, Leah BMJ Open Gastroenterol Hepatology OBJECTIVE: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement and adherence to a low-energy diet (LED) as a treatment option for NAFLD. DESIGN: 23 patients with NAFLD enrolled in a LED (~800 kcal/day) were individually interviewed. Transcripts were thematically analysed. RESULTS: 14/23 patients achieved ≥10% weight loss, 18/23 achieved ≥7% weight loss and 19/23 achieved ≥5% weight loss. Six themes were generated from the data. A desire to achieve rapid weight loss to improve liver health and prevent disease progression was the most salient facilitator to engagement. Early and significant weight loss, accountability to clinicians and regular appointments with personalised feedback were facilitators to engagement and adherence. The desire to receive positive reinforcement from a consultant was a frequently reported facilitator to adherence. Practical and emotional support from friends and family members was critically important outside of the clinical setting. Irregular working patterns preventing attendance at appointments was a barrier to adherence and completion of the intervention. CONCLUSIONS: Engagement and adherence to a LED in patients with NAFLD were encouraged by early and rapid weight loss, personalised feedback and positive reinforcement in the clinical setting combined with ongoing support from friends and family members. Findings support those identified in patients who completed a LED to achieve type 2 diabetes remission and highlight the importance of behaviour change support during the early stages of a LED to promote adherence. BMJ Publishing Group 2021-07-29 /pmc/articles/PMC8323391/ /pubmed/34326098 http://dx.doi.org/10.1136/bmjgast-2021-000678 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Hepatology
Scragg, Jadine
Hallsworth, Kate
Taylor, Guy
Cassidy, Sophie
Haigh, Laura
Boyle, Marie
Anstee, Quentin
McPherson, Stuart
Avery, Leah
Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
title Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
title_full Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
title_fullStr Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
title_full_unstemmed Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
title_short Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
title_sort factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
topic Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323391/
https://www.ncbi.nlm.nih.gov/pubmed/34326098
http://dx.doi.org/10.1136/bmjgast-2021-000678
work_keys_str_mv AT scraggjadine factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT hallsworthkate factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT taylorguy factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT cassidysophie factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT haighlaura factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT boylemarie factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT ansteequentin factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT mcphersonstuart factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease
AT averyleah factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease